Press release
Disease Management Apps Market Outlook 2024: Exclusive Report By The Business Research Company | Alphabet Inc., International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V. , Garmin International Inc., DexCom Inc., Epic S
Disease Management Apps Market Size
The Business Research Company offers in-depth market insights through Disease Management Apps Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The disease management apps market size has grown rapidly in recent years. It will grow from $10.17 billion in 2023 to $11.55 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to infrastructure development boom, mining and quarrying activities, agricultural mechanization, government infrastructure investment, global economic growth.
The disease management apps market size is expected to see rapid growth in the next few years. It will grow to $18.96 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to renewable energy projects, focus on sustainable construction practices, e-commerce infrastructure development, rise in disaster response and recovery efforts, global urban population growth. Major trends in the forecast period include enhancement of operator comfort and safety, application of advanced materials for durability, integration of intelligent machine control systems, focus on modular and versatile attachments, implementation of predictive maintenance technologies, adoption of remote control and teleoperation..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13426&type=smp
Market Segmentation:
The main platform types in disease management apps are iOS, Android, and other platform types. iOS refers to a mobile operating system developed for Apple's mobile devices, including the iPhone, iPad, and iPod Touch. The various devices are smartphones, tablets, and wearables used for various indications such as obesity, cardiovascular issues, mental health, diabetes, and other indications.
Major Driver - Chronic Condition Prevalence Fuels The Expansion Of The Disease Management Apps Market
The increasing prevalence of chronic disorders is expected to propel the growth of the disease management apps market going forward. Chronic conditions also known as chronic diseases refer to long-lasting medical conditions that persist over an extended period, typically for three months or more. Disease management apps are in chronic diseases for providing tools to track symptoms, log medication intake, monitor vital signs, and identify triggers. For instance, in September 2022, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by chronic diseases every year across the globe. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the increasing prevalence of chronic conditions is driving the growth of the disease management apps market going forward.
Competitive Landscape:
Major companies operating in the disease management apps market report are Alphabet Inc., International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V. , Garmin International Inc., DexCom Inc., Epic Systems Corporation, Teladoc Inc. , Fitbit LLC, athenahealth Inc., Allscripts Healthcare Solutions Inc., Omada Health Inc., Calm.com Inc., Livongo Health Inc., American Well Corporation, MyFitnessPal Inc., Talkspace Inc., Noom Inc., Ada Health GmbH, Healthy.io.Ltd., Medisafe International LLC, Sleep Cycle AB, Buoy Health Inc., Azumio Inc., Propeller Health Inc., Welldoc Inc., Informed Data Systems Inc., Curable Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report
Top Trend - Companies Harness Genai For Enhanced Profitability In The Disease Management Apps Market
Major companies operating in the disease management apps market are focusing on technological advancements such as GenAI to increase their profitability in the market. GenAI is an artificial intelligence technology that enables the automation of clinical summary report generation and enhances communication between patients and providers. For instance, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, launched the GenAI artificial intelligence (AI) disease management platform technology using Google Cloud. This latest technology is specifically designed to integrate into its disease-management platform to improve the decision-making tools for diagnostic treatment and recommendations.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Disease Management Apps Market Characteristics
3. Disease Management Apps Market Trends And Strategies
4. Disease Management Apps Market - Macro Economic Scenario
5. Disease Management Apps Market Size And Growth
…..
27. Disease Management Apps Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Disease Management Apps Market Outlook 2024: Exclusive Report By The Business Research Company | Alphabet Inc., International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V. , Garmin International Inc., DexCom Inc., Epic S here
News-ID: 3435973 • Views: …
More Releases from The Buisness Research Company
Organic Period Care Products Market Anticipated To Witness Robust Growth, Surpas …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Organic Period Care Products Market Size and Its Estimated Growth Rate?
The size of the market for organic period care products has significantly expanded in recent years, and it's projected to escalate from $2.63 billion in 2024 to $2.83 billion in 2025, with a compound annual growth rate…
Porous Ceramics Market 2024: Trends, Industry Insights, and Growth Drivers
The Business Research Company recently released a comprehensive report on the Global Porous Ceramics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
AI in Automotive & Transportation Market 2024: Key Trends and Growth Outlook
The Business Research Company recently released a comprehensive report on the Global AI In Automotive And Transportation Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The …
Anosmia Global Market 2024 Strategic Outlook Emerging Trends and Market Forecast
The new report published by The Business Research Company, titled Anosmia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the anosmia market size has grown strongly in recent years. It will grow from $3.24 billion in 2023 to $3.55…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
